WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today released new data on the bioscience industry in the United States.
The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.
- The nation’s bioscience industry employed 1.87 million workers across more than 101,000 U.S. business establishments in 2018.
- The bioscience industry’s total economic impact on the U.S. economy totaled $2.6 trillion dollars in 2018, as measured by overall output.
- Small and mid-sized biopharmaceutical companies comprised 71% of total biopharmaceutical industry employment and 99% of the business establishments.
- Smaller biopharmaceutical firms play a key role in innovation and have accounted for 60% or more of all FDA drug approvals each year over the past three years (2017-2019).
- As of mid-May 2020, there were more than 400 drug programs in development aimed at eradicating the COVID-19 disease, including 100 vaccine programs and 135 antiviral drug programs.
“For years, this report has put a spotlight on the immense impact America’s bioscience industry has on the economy, job creation, and economic output. Now, as we endure the Coronavirus pandemic, it is encouraging to see industry at record strength as it took on the threat,” said Pete Pellerito, BIO Senior Policy Adviser for Federal and State Economic Development and Technology Transfer Initiatives.
“The bioscience industry has a strong track record of near continuous growth and will be more important than ever to help end the pandemic and rebuild our global economy,” said Ryan Helwig, Principal and Project Director with TEConomy Partners.
The state-by-state industry assessment is the ninth in a biennial series, developed in partnership by TEConomy and BIO, and studies the state of the U.S. bioscience industry and its associated innovation ecosystem at the national, state, and metropolitan area levels.
The report includes individual fact sheets for all 50 states, the District of Columbia and Puerto Rico, which can be found alongside the full report and interactive map at www.bio.org/jobs.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
About TEConomy Partners
TEConomy Partners, LLC is a global leader in research, analysis and strategy for innovation-driven economic development. Today we’re helping nations, states, regions, universities and industries blueprint their future and translate knowledge into prosperity. The principals of TEConomy Partners include the authors of the prior Battelle/BIO State Bioscience Development reports, published since 2004. For further information, please visit www.teconomypartners.com.